Atahar imam Hasan: Universal Artificial Blood and the Future of Trauma Care
Atahar imam Hasan, Internship Trainee at Yacca Group, shared a post on LinkedIn:
“Japanese scientists at Nara Medical University are developing a universal artificial blood that could transform transfusion medicine.
Produced by extracting hemoglobin from expired donor blood and encapsulating it in lipid-based particles that mimic red blood cells, it can safely transport oxygen without requiring blood type matching.
Unlike donated blood, which requires refrigeration and expires in about 42 days, this artificial blood can be stored for up to two years at room temperature (or five years when refrigerated).
Its long shelf life, universal compatibility, and lower risk of transfusion-transmitted infections make it especially valuable for trauma care, disaster response, military medicine, and regions with limited blood supplies.
Human trials that began in 2022 have shown the artificial blood to be safe in healthy volunteers, with no serious side effects. Larger-dose studies (100–400 mL) are now underway to further assess its safety and effectiveness.
If successful, it could be introduced into hospitals by around 2030, marking one of the most significant advances in transfusion medicine in decades.
Source: Laws, J. (2025). Artificial Blood That Could Work for All Blood Types in Trials. Newsweek.”

Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI